Moderna (MRNA) PT Raised to $68 at Roth Capital
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $158.83 +14.36%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
Roth Capital analyst Yasmeen Rahimi raised the price target on Moderna (NASDAQ: MRNA) to $68.00 (from $41.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Moderna (MRNA) to Peerperform
- Pinduoduo Inc. (PDD) PT Lowered to $114 at Benchmark on Cautious Near-Term View
- Lululemon (LULU) PT Lowered to $120 at UBS on Expectations for Lowered FY26 Guidance
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
